Eisai

Eisai unit hands over $46M for Japanese rights to Newron’s schizophrenia add-on
Fierce Biotech
Sun, 12/15/24 - 10:48 pm
Newron Pharma
Eisai
schizophrenia
evenamide
Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome
Fierce Pharma
Mon, 11/18/24 - 06:36 pm
Eisai
obesity
lorcaserin
Eisai wins over European regulators on Alzheimer’s drug Leqembi
BioPharma Dive
Thu, 11/14/24 - 10:28 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
BioSpace
Sun, 11/10/24 - 09:27 pm
Eisai
Biogen
Leqembi
earnings
Alzheimer's disease
Eisai dials back forecasts for Alzheimer's drug Leqembi
Pharmaphorum
Fri, 11/8/24 - 11:38 am
Eisai
earnings
Leqembi
Alzheimer's disease
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Pharmaphorum
Fri, 11/1/24 - 10:57 am
Eisai
Biogen
Leqembi
Alzheimer's disease
FDA
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Fierce Pharma
Mon, 10/14/24 - 11:13 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
ESMO: Despite checkered past, Merck's Keytruda-Lenvima pairing looks to change practice in liver cancer subtype
Fierce Pharma
Sun, 09/15/24 - 06:30 pm
ESMO
Merck
Eisai
Keytruda
Lenvima
liver cancer
Eisai, Biogen's Leqembi nabs UK nod, but reimbursement remains elusive
Fierce Pharma
Thu, 08/22/24 - 11:45 am
Eisai
Biogen
Leqembi
UK
Alzheimer's disease
Eisai plants molecular glue SEED with $1.5B biobucks deal in neuro, oncology
Fierce Biotech
Tue, 08/6/24 - 11:14 am
Eisai
molecular glue
biobucks
Seed Therapeutics
After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wed, 07/31/24 - 10:25 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tue, 07/30/24 - 11:37 am
Eisai
EMA
Europe
Leqembi
Biogen
Alzheimer's disease
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Fierce Pharma
Fri, 07/26/24 - 11:15 am
Eisai
Biogen
Leqembi
Europe
Eisai adopts Medidata’s AI-driven platform for clinical trials
Clinical Trials Arena
Fri, 07/26/24 - 11:13 am
Eisai
Medidata
clinical trials
artificial intelligence
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive
Fri, 07/12/24 - 11:29 am
Eisai
Biogen
Leqembi
Alzheimer's disease
Roche
Spark Therapeutics
gene therapy
layoffs
Leqembi gains approval for Alzheimer’s treatment in Israel
Pharmaceutical Business Review
Fri, 07/12/24 - 11:12 am
Eisai
Israel
Alzheimer's disease
Leqembi
BioArctic
BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival
Fierce Biotech
Mon, 07/1/24 - 11:29 am
Bristol Myers Squibb
Eisai
antibody-drug conjugate
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Reuters
Fri, 06/28/24 - 11:18 am
Eisai
Biogen
Alzheimer's disease
Leqembi
China
Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
Pharma Voice
Fri, 06/28/24 - 11:17 am
Big Pharma
Neuroscience
Prothena Biosciences
Biogen
Eisai
Pfizer
AbbVie
Eli Lilly
Bristol Myers Squibb
What Would a Donanemab Approval Mean for Leqembi?
BioSpace
Mon, 06/24/24 - 10:47 am
Eli Lilly
donanemab
Biogen
Eisai
Leqembi
FDA
Alzheimer's disease

Pages